The analyzer is the first in the Alinity hematology series of instruments to be commercially released, and is part of the planned integrated hematology system designed to address the productivity needs of the high-volume laboratory.
Hematology is a medical specialty dedicated to studying the physiology of blood, and the cause, diagnosis, treatment, and prevention of diseases related to blood. In diagnostics testing, hematology tests look at blood composition, which includes the identification and quantification of different types of blood cells. The Alinity hq analyzer automates the performance of these tests and reports on 29 different parameters within a matter of minutes.
“The Alinity hq launch is a key milestone for Abbott’s hematology business unit. Abbott is leading the way to providing a more efficient, complete lab solution that no competitor in the industry can match,” said Luis de Luzuriaga, divisional vice president and general manager for Abbott’s hematology business. “With the Alinity family of harmonized systems, Abbott aims to simplify diagnostics testing across laboratory disciplines and help our customers improve patient outcomes.”
Click here to read the full press release >>
News From Our Partners
